Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2025

Genmab — September 2025

Planlagt Fastgjort Låst Flyttet Genmab
283 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #128

    Guggenheim analyst Michael Schmidt upgraded Genmab (GMAB) to Buy from Neutral with a $43 price target, citing increased conviction in Epkinly’s outlook https://www.tipranks.com/news/the-fly/genmab-upgraded-to-buy-at-guggenheim-on-royalty-revenue-upside-potential-thefly

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #129

      Genmab: Major Shareholder Announcement https://proinvestor.com/investornyt/1364289/major-shareholder-announcement

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #130

        Genmab får købsanbefaling fra amerikansk børshus: Ser potentiale på 50 pct. https://proinvestor.com/investornyt/1364272/genmab-far-kobsanbefaling-fra-amerikansk-borshus-ser-potentiale-pa-50-pct

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JKY_VH
          wrote on sidst redigeret af
          #131

          Tak for den Helge:-)

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #132

            Genmab får ny storaktionær https://proinvestor.com/investornyt/1364304/genmab-far-ny-storaktionaer

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #133

              Orbis was set up in 1989. Our founder Allan Gray believed that a fundamental, contrarian long-term approach offered great potential. If he applied it successfully, he could help people grow their money meaningfully over time.

              Until 2015, our Funds were only available to institutions, like pension funds, with millions to invest. But we wanted to make investing in funds simpler and more accessible for everyone.

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #134

                Læs mere om den nye storaktionær: https://www.orbis.com/uk/individual/about-us/about-us

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bikube
                  wrote on sidst redigeret af
                  #135

                  Er det ikke ca. 14 dage siden, at vi sidst snakkede om den nyhed.

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #136

                    Børsmeddelelsen er kommet i dag.

                    1 Reply Last reply
                    0
                    • R Offline
                      R Offline
                      Raun
                      wrote on sidst redigeret af
                      #137

                      Er der et modstandspunkt her 1820-1830 stykker - Synes det virker til at aktien har det svært i dette niveau?

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        Dusør
                        wrote on sidst redigeret af
                        #138

                        En lille pause efter 500 kr op på rekord tid. Så er den klar til et ryk mere, samme størrelse vil være fint.

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bikube
                          wrote on sidst redigeret af
                          #139

                          Vi så tidligere listen over de største aktionærer, og Orbis stod der med to fonde, der tilsammen havde over 5%.

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #140

                            Ok Bikube.

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #141

                              New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies https://www.prnewswire.com/news-releases/new-novartis-data-further-support-benefits-of-kesimpta-in-relapsing-ms-following-switch-from-oral-disease-modifying-therapies-302565142.html

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #142

                                Johnson & Johnson at Bernstein Forum: Strategic Growth and Innovation https://www.investing.com/news/transcripts/johnson--johnson-at-bernstein-forum-strategic-growth-and-innovation-93CH-4253958

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #143

                                  Var der noget nyt fra Pagano på Bank of America Global Health conference ?

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GUHO
                                    wrote on sidst redigeret af
                                    #144

                                    Thanks for the link EL. The outlook for Rybrevant seems very encouraging. As I understand it, they indicate that Rybrevant can reach 4 billion dollars as fast as in 2028 with a peak above 5 billion

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #145

                                      Ugekommentar. Genmab 07.32. Kort video: https://proinvestor.com/boards/128565

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #146

                                        Trump varsler 100 procents told på flere lægemidler https://proinvestor.com/investornyt/1365456/trump-varsler-100-procents-told-pa-flere-laegemidler

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #147

                                          Danske life science: Torsdagsklø, men hvad venter fredag? https://proinvestor.com/boards/128587

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper